Compare Novavax Inc (NVAX) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs SoFi Technologies Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while SoFi Technologies Inc trades at $17.63 (market cap $21.82B). The key difference: SoFi Technologies Inc is far larger — about 16.8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SOFI | |
|---|---|---|
Market Cap | $1.30B | $21.82B |
Sector | Health | Financials |
52-Week High | $11.19 | $32.21 |
52-Week Low | $6.22 | $15.15 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
